We described a partitioned enzyme-sensor system, which incorporates an immobilized substrate and three or more discrete immobilized enzymes. This instrument measures a-amylase activity by passing the solution containing aamylase over a column packed with immobilized starch.
a three-electrode amperometric cell. All immobilized reagents were immobilized on a particulate, porous alumina to allow rapid and constant flow rate. With use of less than optimum immobilized reagents, a-amylase activity has been measured from about 5 to 200 kU/liter with a 50-rl sample size. Lack of sensitivity is predominantly attributable to the low activity and low stability of immobilized maltase and glucoamylase. We believe that a clinical test using this system is feasible and desirable because the immobilized reagent system should allow for testing of a-amylase with excellent precision, convenience to the operator, and low cost.
AddItional Keyphrases: enzyme activity . enzymatic methods . amperometry Clinical tests for a-amylase (EC 3.2.1.1) should satisfy four conditions. First, the test must eliminate or minimize interferences.
Second, the test must be easy and simple to perform and require little technician training time. Third, the test must be economical. Finally, the test must be sensitive over a wide range of a-amylase values and require only one or two sample pretreatments.
There are many methods for a-amylase, each of which has been modified several times (2) (3) (4) (5) . For example, a reducing agent was used by Somogyi to detect the sugars formed by a-amylase catalysis (6) . Many other researchers have found it advantageous to modify his original procedure (7) . Later it was observed that some blood components competed with the substrate starch for the available iodine in the test (8, 9) . This competition for iodine can be eliminated by using a starch derivative containing a dye (10) or a p-nitrophenol chro-mophore (11) . In addition, novel substrates such as DyAmyl-L (12) or those used in radioimmunoassay techniques (13) have also been developed to further reduce interferences.
Kinetic mode a-amylase tests (14) , in which soluble reagent enzymes are used, have been developed and modified to eliminate interferences, but they still require considerable technician care in the preparation and storage of enzyme solutions. Furthermore, each enzyme reagent solution is discarded after use and stock solutions are often difficult to store from day to day, adding to the cost per test.
The use of immobilized enzymes in clinical instruments has several unique advantages over the corresponding use of their soluble counterparts (15) . Immobilized enzymes are convenient because no enzyme solution need be prepared nor is it necessary to ref rigerate the immobilized enzyme reagent when it is not in use. Immobilized enzymes have predictable initial activity and rates of decay. In addition an immobilized enzyme reagent often can be used for hundreds or thousands of tests and so is generally less expensive per test than its soluble counterpart.
Partitioned enzyme-sensor instruments connect immobilized reagents to electrochemical sensors by means of a flowing stream (1) . The Kimble BUN Analyzer is an example of this type of instrument (16) (17) (18) . In this instrument, serum or plasma samples flow through the cartridge containing immobilized urease, the pH of the sample stream is then increased and the stream passes through an ammonia sensor system. Because the enzyme and the sensor are separated by a flowing stream it is possible to use optimum conditions for each. Purification required before any enzyme was immobilized is described in the next section. Potato amylose (Sigma Chemical Co; Type II, practical grade, lot 85B-30919) was used exclusively as the starting material for immobilized starch. All other chemicals were reagent grade. De-ionized, distilled water was used to prepare reagents.
Methods
Catalase was extracted from crude commercial glucose oxidase by chromatography on w-aminodecyl agarose (Miles Laboratories, Inc., Code 62-8042). First, glucose oxidase was dissolved and dialyzed against phosphate buffer (2 mmol/liter, pH 6.0). After dialysis the sample was filtered through a 0.2-iim (av pore size) TCM filter (Gelman Instrument Co., Ann Arbor, Mich. 48106). The sample was adsorbed on the above column (2 X 11 cm) of hydrophobic agarose equilibrated with the same phosphate buffer. The enzymes were eluted with a salt gradient (0-1.0 mol/liter NaCl) in phosphate buffer. One protein peak contained predominantly catalase (620 kU/g), which eluted first; the other contained predominantly glucose oxidase (35 kU/g) and eluted at an NaC1 concentration of 0.1 mol/liter. Four experimental systems were studied to determine the best arrangement and amounts of immobilized reagents and buffers. The flow diagram for systems 2, 3, For System 1. buffer 2, pump 2. and the mIxer are removed. All systems were operated at room temperature (20 to 23 #{176}C) and 4is shown in Figure 1 . For system 1, buffer 2, pump 2, and the mixer are removed. The residence time of the sample in system 1 containing only one flowing channel is approximately 1 mm, while the flow rate for each channel in systems 2,3, and 4 was set at 1 mi/mm. In the other systems which contained considerably more immobilized reagents, and thus more volume between the injection point and the detector, the sample residence time was longer. Although maltose injections were observed after 5 mm, the products of a-amyiase-induced degradation of the immobilized starch were often detected as late as 15 mm after injection. This retardation is presumably due to the binding of a-amylase in the "substrate stage" of the system. We did not attempt, in any system, to control temperature, which fluctuated between 20 and 23 #{176}C.
Maltase for system 2 was recrystallized from a 25-50% saturated ammonium sulfate solution. The immobilized glucoamylase in system 3 and the immobilized glucoamylase "B" in system 4 were prepared from crude glucoamylase without purification. The immobilized glucoamylase "A" in system 4 was prepared from the soluble glucoamylase fraction that was eluted first from chromatography (6.5 X 118.0 cm) on a column containing a polysaccharide gel (G-100; Pharmacia, Inc., Piscataway, N.J. 08854). The active fraction in the elution was immobilized without isolation. The elution buffer consisted of 60 mmol/liter phosphate buffer, pH 6.0, containing 1.0 mmol of NaCN per liter.
Catalase and glucoamylase in systems 3 and 4 were immobilized by a procedure previously reported (19) . All other enzymes were immobilized by methods developed to immobilize glucose oxidase for the Kimble Glucose Analyzer (Barabino, R. C., Jones, M. D., and Keyes, M. H., Development of immobilized glucose oxidase reagent for the Kimble Glucose Analyzer, in preparation).
Starch was also immobilized on particu- late porous alumina. Commercial samples of a-amylase were analyzed for the presence of glucose by use of the hexokinase reference method (20) .
Assay of Soluble and Immobilized Enzymes
The assay procedures for both native and immobilized enzymes were identical. Assays were performed on the Model 53 Oxygen Monitor (Yellow Springs Instrument Co., Yellow Springs, Ohio 45387). For glucose oxidase the rate of decrease in oxygen concentration was measured in a solution containing, per liter, 10 mmol of
maleate buffer (10 mmol/ liter, pH 5.6) and H202 (1.4 g/kg).
Glucoamylase and maltase activities were evaluated by placing enzyme samples in a solution containing, per liter, 6 to 10 mmol of maltose and 10 mmol of phosphate buffer, pH 6.0. Two-microliter samples of solution were withdrawn and glucose measured with a glucose oxidase-based method. All enzyme activities are reported in international (IUB) enzyme units, U, except as noted in the tables.
Results and Discussion
The four experimental flow-systems were tested to determine the feasibility of measuring a-amylase activity. The buffers used for each system are listed in Table 1 and the immobilized reagents with their corresponding activities are listed in Table 2 .
The sample was injected with a syringe directly into a cartridge containing immobilized starch. At this stage, the amylase present in the sample hydrolyzes some of the starch, releasing oligosaccharides ("substrate stage"). The sample then flows into another cartridge containing four layered immobilized enzymes. The first layer in this cartridge contains immobilized glucose oxidase and catalase mixed together, which converts the glucose initially present in the sample to water, oxygen, and gluconic acid ("scavenger stage"). The next layer consists of either immobilized glucoamylase or maltase, which hydrolyzes the oligosaccharides to D-glucose ("glucose generating stage"). The final portion of the cartridge is made up of immobilized, catalase-free glucose oxidase, which converts the newly-formed glucose to H202 and gluconic acid ("H202 generating stage"). A three-electrode amperometric detector identical to the detector developed for the Kimble Glucose Analyzer is used to detect the H202. The signal generated by the H202 can be related to the quantity of a-ainylase in the sample injected.
Using system 1, we generated signals by injecting samples of a 85 mg/liter a-amyiase solution having an activity of 44 kU/liter. This solution of a-amylase is essentially free of glucose (<1 X 10 g/liter) so that no signal is generated from glucose present as a contaminant. Since no scavenger stage was included, the instrument was calibrated by injecting 20 tl of a 2 g/liter glucose solution. The results for system 1 are illustrated in Figure 2 . Each volume of solution was injected three times and the average signal obtained is plotted.
The results obtained with system 2 are shown in Figure 3 . The inclusion of a scavenger stage made it impossible to calibrate the instrument by using a glucose solution. For this system, the sample volume was held constant at 50 1.d, and samples of a-amylase at several concentrations were injected. In both systems 1 and 2, the signal was too low to measure a-amylase activity in normal serum or plasma, even though system 2 contained about 100-fold more immobilized starch in the substrate stage and about threefold more glucose oxidase in the H202 generating stage than did system 1.
The results from systems 1 and 2 suggest that the low signal generated from injection of a-amylase samples is due primarily to the low efficiency of the immobilized maltase. Therefore, glucoamylase was immobilized instead of maltase for use in systems 3 and 4. Table 3 illustrates the typical results with system 3 in which 100-Cosceatritia, lkU/Iiter)'lOt The signal detected was plotted vs. the concentration of the a-amylase solutIon injected. The injected volume was 50 iI and the flow rate generated by each pump was 1 mi/mln jl samples were injected. Very large signals were obtained for glucose and H202, possibly because insufficient quantities of immobilized glucose oxidase and catalase were present in the scavenger stage, but more probably because of insufficient dissolved oxygen for the complete conversion of glucose to giuconic acid, oxygen, and water during the scavenger stage. In the Kimble Glucose Analyzer a sample volume of 2 il is used to ensure complete conversion of glucose to H202 for glucose concentrations up to 4 g/liter without oxygen depletion. Although there is certainly more diffusion and dilution of the sample in systems 2,3, and 4 than in the Kimble Glucose Analyzer, owing to the larger volume of reagents, it seems unlikely that a sample volume 50-fold larger than the one recommended for the Kimble Glucose Analyzer could be used without complete depletion of oxygen.
In system 4 the sample size was decreased to 20 il for the reason stated above. This system is also improved by the incorporation of samples from two different immobilized glucoamylase batches. Batch "A" was prepared after purification of crude glucoamylase, whereas batch "B" was the same immobilized crude glucoamylase used in system 3. As can be seen in Figure  4 , this system generated a very large signal on injection of maltose samples and low signals for either glucose or hydrogen peroxide. As shown in Figure 4 , signals comparable in magnitude to the injected maltose samples were detected with the injection of a-amylase solutions. Repeated injection of a-amylase samples caused a rapid loss in signal, presumably due to the loss in activity of the immobilized glucoamylase. Future work is necessary to improve the stability of the immobilized glucoamylase so that a reliable, sensitive measurement of aamylase can be. performed at the concentrations found in normal serum and plasma. Table 4 lists the total initial activities for each component in each system.
Summary and Conclusion
Two conclusions can be drawn from the results of systems 1 through 4. System 1 gave results similar to system 2, even though system 2 included about 100-fold more immobilized starch and three-fold more glucose oxidase. Apparently, the low signal generated by aamylase samples is due to poor conversion of oligosaccharides to glucose. With improvement in the glucose generating stage, a large signal due to maltose was detected in system 3, but the a-amylase signal remained quite low. The signal generated by a-amylase was substantially larger in system 4, which included a fraction of immobilized purified glucoamylase. Although the total activity of immobilized glucoamylase is only about one-third higher for system 4 (as measured by using maltose as a substrate) than for system 3, the signal due to a-amylase increased about 10-fold. Such a result suggests that the purified glucoamylase hydrolyzes the oligosaccharides of starch degradation more efficiently than does the crude enzyme, even though each is equally effective towards maltose. Possibly the crude preparation of glucoamylase contains more than one enzyme that hydrolyzes oligosaccharides. Further investigations are being undertaken to determine the enzyme compositions of the crude and purified glucoamylase solutions. The results of system 4 indicate that sufficient sensitivity to a-amylase is generated to make this test procedure useful in determining a-amylase activities at clinically significant levels.
It should also be noted that the scavenger in system 4 was quite effective with glucose oxidase and catalase activities of about 100 U each. Possibly reduction to a sample volume of 10 il will be all that is required to completely remove the signal due to serum or plasma glucose.
It is generally agreed that enzyme immobilization results in a reagent that is more convenient, more stable, and usually less expensive than its soluble counterpart. User convenience and prolonged enzyme stability have been demonstrated by two commercial instruments in which immobilized enzymes are used, Yellow Springs Instruments' Glucose Analyzer and the Kimble BUN Analyzer (16, 21) . We have demonstrated the feasibility of coupling four immobilized reagents for the determination of another constituent of serum and plasma, a-amylase, at clinically significant levels.
Methods incorporating coupled immobilized reagents (enzymes, substrates, and cofactors) in sequence thus seem practicable and feasible. With use of a partitioned enzyme-sensor system, the reaction conditions for each reagent stage may be optimized, something that is not always possible with soluble coupled enzyme reactions.
